Article Details
Retrieved on: 2022-11-16 02:31:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
“Currently approved proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies demonstrated robust LDL-C-lowering efficacy at ...
Article found on: www.physiciansweekly.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here